language.en-US
  • EN
  • RU
WHO guideline on treatment of drug-resistant tuberculosis, 2022 update

20th webinar of the Virtual Medical Consilium (VMC) of the WHO Regional Office for Europe devoted to the 2022 update of the WHO DR-TB treatment guideline, held on February 24th, 2023 

The webinar agenda includes: 

• Welcoming remarks. Dr Askar Yedilbayev, Team Lead (TB), Mr Oleksandr Korotych, Technical Officer, Joint Infectious Diseases Unit, WHO Regional Office for Europe, Denmark. 

• Development principles and key recommendations of the WHO DR-TB treament guideline 2022 update. The 6-month BPaL(M) regimen and the evidence behind the recommendation for its programmatic use. Dr Fuad Mirzayev, Team Leader of the WHO’s Global Tuberculosis Programme, Switzerland. 

• Assessment of country’s preparedness to introduction of BPaL(M) into the programmatic practice. Dr Nino Lomtadze 

• Country early experience on the introduction and scale up of BPaL(M). Prof Alena Skrahina, Deputy Head of NTP, Belarus. 

• Questions and Answers.

 

1 DR-TB treatment guidelines update_2022.pdf 1 DR-TB treatment guidelines update_2022-RUS.pdf 2 BPaLM country preparedness_N. Lomtadze_ENG_20th VMC webinar.pdf 2 BPaLM country preparedness_N. Lomtadze_RUS_20th VMC webinar.pdf.pdf 3 Country early experience_BPaLM_6.ru.pdf 3 Country early experience_BPaLM_6.eng.pdf